Comparison scoring model of severe viral hepatitis and model of end stage liver disease for the prognosis of patients with liver failure in China

Figure 1 Kaplan-Meier survival curves for group A (at low risk, SMSVH scores ≤ 4) and group B (at high risk, SMSVH scores ≥ 5).

Figure 2 Kaplan-Meier survival curves for group C (SMSVH score unchanged or increased) and group D (SMSVH score decrease by 1) and group E (SMSVH score decreased by 2 or more) after 2 wk of medical therapy.

Figure 3 ROC curves for the 6-mo survival rate estimated with MELD and SMSVH at baseline (SMSVH0) and after 2 wk of medical therapy (SMSVH1).